Navigation Links
PolyGel Signs Long Term Exclusive Agreement With China's Largest Distributor of Healthcare Products
Date:7/26/2011

WHIPPANY, N.J., July 26, 2011 /PRNewswire/ -- PolyGel, the manufacturer of Orthopedic, Therapy and Skin Care Products, has signed a long term exclusive distribution agreement with China National Pharmaceutical Foreign Trade Corporation (Sinopharm Foreign Trade). Based in Beijing, China, Sinopharm Foreign Trade is a wholly-owned subsidiary of China National Pharmaceutical Group Corporation (SINOPHARM Group).

(Photo:  http://photos.prnewswire.com/prnh/20110726/NY40954 )

The Sinopharm Group is the largest distributor of pharmaceutical and healthcare products in China, with 2010 revenues of over 69.2 billion RMB (approximately $10.45 billion US).

Sinopharm's motto of "Caring for Life-Attending to Health" is a good match for PolyGel's motto of "Improving Well Being". By working together, new Sinopharm/Poly Gel programs and products will be developed and sold into the pharmacy, professional, medical, consumer and Internet market channels across China.

The GDP of China has surpassed Japan to become the second largest economy in the world in 2010. Driven by the continuous increase in national medical and healthcare expenditures, the government's further investment in the medical and healthcare sectors and the effects of medical reform in China, this market will continue to experience rapid growth.

About Diabetes in China

An important part of the PolyGel program will focus on the growing population of diabetics in China. According to a study published in the March 25, 2010 edition of the New England Journal of Medicine, China now has more people with diabetes than any other country in the world, with more than 92 million adults diagnosed with diabetes and another 150 million more are on their way to developing it.

PolyGel's innovative orthopedic and skin care products incorporate proprietary gel formulations, textiles and materials. PolyGel is well known in the United States and Europe as a leading manufacturer of foot care, rehabilitation, sports medicine and consumer healthcare products.  PolyGel core gel materials have been manufactured for over 30 years under the direction of Lawrence Kersen, PolyGel President, and are sold throughout the world.  Quality and consistency are PolyGel hallmarks. When combined with Sinopharm's national distribution network and educational resources, a new level of public and professional awareness will be created to inform both the public and professional communities about the dangers of the diabetic epidemic in China. PolyGel has developed a family of "Diabetic Friendly" products to help minimize potential complications as well as to help treat diagnosed problems.

"Both Sinopharm and PolyGel are very excited about our agreement" said Lawrence Kersen.  "This new partnership gives Sinopharm a supplier of high quality, innovative and cost effective products that will help PolyGel build a strong market presence in this important and growing market, especially in the diabetic area."

For more information on PolyGel, visit our websites at www.polygel.com and www.gelsmart.net.


'/>"/>
SOURCE PolyGel
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. PolyGel® Receives SADMERC Approval for L-Code L3670 for ThermoActive™ Cold & Hot Mobile Compression Shoulder Orthosis
2. PolyGel® Receives SADMERC Approval for L-Code L0627 for New ThermoActive™ Plus Cold & Hot Compression Lumbar Orthosis
3. NSVascular, Inc., a NeuroSigma Subsidiary, Signs an Exclusive License Covering UCLAs Thin-Film Nitinol (TFN) Stent Technology for Endovascular Applications
4. NeoStem Signs Definitive Merger Agreement to Acquire Amorcyte in Equity Transaction
5. Dynatronics Signs Agreement With CHAMPS Group Purchasing
6. Panacea Global, Inc. Signs Multi-year Contract Valued at Minimum $8.75 Million for Cancer Detection System with Palmverse Limited
7. InspireMD Broadens Global Distribution Network; Signs Distributor for the Russian Federation
8. TPI Signs Macrolide API International Sales and Marketing Agreement
9. Perma-Fix Signs Option Agreement to License Technology for Use in Proprietary Process to Produce Medical Isotopes
10. Hope Paige Designs Medical ID Bracelets Now Available in 1,100 Additional Locations
11. Cancer Research UK Signs Deal With Centella Therapeutics, Inc. to Launch Clinical Development of Radiotherapy-Enhancing Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... 2016 One of Australia,s successful ... of a new biotechnology company, Noxopharm Limited [ABN 50 608 966 ... and to list on the ASX. Noxopharm is a ... enter a Phase 1 clinical study later this year. ... of the biggest problems facing cancer patients - the ability of ...
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/26/2016)... -- VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) reported today ... to build a strong and stable market for trading ... the OTC Markets-pink current trading platform. Explains ... seeing an anomaly in market trading activities that may ... Company, but shareholders and market players as well. I ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... closing of Bruton Memorial Library on June 21 due to a possible lice infestation, as ... of head lice: the parasite’s ability to live away from a human host, and to ... one in the event that lice have simply gotten out of control. , As lice ...
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from PsychTests.com reveals ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... Fla. (PRWEB) , ... June 24, 2016 , ... Global ... Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition ... Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this year’s ...
Breaking Medicine News(10 mins):